Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4608]

Negative trade-off between neoantigen repertoire breadth and the specificity of HLA-I molecules shapes antitumour immunity

Negative trade-off between neoantigen repertoire breadth and the specificity of HLA-I molecules shapes antitumour...

FDA approves pembrolizumab for high-risk early-stage triple-negative breast cancer

FDA approves pembrolizumab for high-risk early-stage triple-negative breast cancer

Study identifies biomarker for breast cancer response to immunotherapy

Study identifies biomarker for breast cancer response to immunotherapy

New breakthrough to help immune systems in the fight against cancer

New breakthrough to help immune systems in the fight against cancer

Phase two CD19-antibody-drug conjugate trial demonstrates promise for aggressive lymphoma

Phase two CD19-antibody-drug conjugate trial demonstrates promise for aggressive lymphoma

Novel imaging agent identifies biomarker for iron-targeted cancer therapies

Novel imaging agent identifies biomarker for iron-targeted cancer therapies

Researchers develop novel therapy that could be effective in many cancers

Researchers develop novel therapy that could be effective in many cancers

New organ-on-a-chip finds crucial interaction between blood, ovarian cancer tumours

New organ-on-a-chip finds crucial interaction between blood, ovarian cancer tumours

Mayo Clinic research suggests women over 65 be offered hereditary cancer genetic testing

Mayo Clinic research suggests women over 65 be offered hereditary cancer genetic testing

Investigational magnetic device shrinks glioblastoma in first-in-world human test

Investigational magnetic device shrinks glioblastoma in first-in-world human test

More from ecancer